CHESTGuidelines & Topic CollectionsAbout CHEST GuidelinesPulmonary Vascular Guidelines and Expert Panel Reports

Pulmonary Vascular Guidelines

Explore our reviews of the management of pulmonary arterial hypertension and the use of antithrombotic therapy for venous thromboembolism disease, thrombosis, and atrial fibrillation.

Guideline in Focus

arterial view

Antithrombotic Therapy in COVID-19

June 29, 2023

This guideline provides recommendations for managing four arterial (pro)thrombotic medical conditions in patients with COVID-19 and assessing the risks and benefits of additional medication.

More pulmonary vascular guidelines


Perioperative Management of Antithrombotic Therapy | August 2022

These recommendations cover the perioperative management of vitamin K antagonists, heparin bridging, antiplatelet drugs, and direct oral anticoagulants. The recommendations also address perioperative management of patients who are undergoing minor procedures.


Antithrombotic Therapy for VTE Disease | August 2021

This guideline and expert panel report covers aspects of antithrombotic management of venous thromboembolism (VTE) from initial management through secondary prevention and risk reduction of postthrombotic syndrome. This is the second update to the ninth edition of these guidelines.

Therapy for Pulmonary Arterial Hypertension in Adults | March 2019

Antithrombotic Therapy for Atrial Fibrillation | November 2018

Antithrombotic Therapy and Prevention of Thrombosis, 9th edition | February 2012


Developing new pulmonary vascular guidelines

CHEST develops trustworthy, evidence-based clinical practice guidelines on the diagnosis and treatment of chest disease states with the help of CHEST members, volunteers, leaders, and staff. Help create high-quality, relevant pulmonary vascular guidelines.